BehaveNet^®
Clinical Capsule™

Join Our Mailing List

For Email Newsletters you can trust

Movies

Facebook

Twitter

drug: ramelteon

Clinical class	hypnotic
Action	melatonin receptor agonist
Chemical class	tricyclic indan derivative
CSA schedule	none
DEA number
Routes of administration	oral
Associated with (substance-related)	disorders: none
Availability	prescription

Rozerem™ (Takeda) FDA approved for treatment of :
7.22.2005 Insomnia characterized by difficulty with sleep onset
US prescribing information